and †Department of Regional Environment, Faculty of Regional Sciences, Tottori University, Japan HS (heparan sulfate) is synthesized by HS co-polymerases encoded by the EXT1 and EXT2 genes (exostosin 1 and 2), which are known as causative genes for hereditary multiple exostoses, a dominantly inherited genetic disorder characterized by multiple cartilaginous tumours. It has been thought that the hetero-oligomeric EXT1-EXT2 complex is the biologically relevant form of the polymerase and that targeted deletion of either EXT1 or EXT2 leads to a complete lack of HS synthesis. In the present paper we show, unexpectedly, that two distinct cell lines defective in EXT1 expression indeed produce small but significant amounts of HS chains. The HS chains produced without the aid of EXT1 were shorter than HS chains formed in concert with EXT1 and EXT2. In addition, biosynthesis of HS in EXT1-defective cells was notably blocked by knockdown of either EXT2 or EXTL2 (EXT-like), but not of EXTL3. Then, to examine the roles of EXTL2 in the biosynthesis of HS in EXT1-deficient cells, we focused on the GlcNAc (N-aetylglucosamine)
HS (heparan sulfate) is synthesized by HS co-polymerases encoded by the EXT1 and EXT2 genes (exostosin 1 and 2), which are known as causative genes for hereditary multiple exostoses, a dominantly inherited genetic disorder characterized by multiple cartilaginous tumours. It has been thought that the hetero-oligomeric EXT1-EXT2 complex is the biologically relevant form of the polymerase and that targeted deletion of either EXT1 or EXT2 leads to a complete lack of HS synthesis.
In the present paper we show, unexpectedly, that two distinct cell lines defective in EXT1 expression indeed produce small but significant amounts of HS chains. The HS chains produced without the aid of EXT1 were shorter than HS chains formed in concert with EXT1 and EXT2. In addition, biosynthesis of HS in EXT1-defective cells was notably blocked by knockdown of either EXT2 or EXTL2 (EXT-like), but not of EXTL3. Then, to examine the roles of EXTL2 in the biosynthesis of HS in EXT1-deficient cells, we focused on the GlcNAc (N-aetylglucosamine) transferase activity of EXTL2, which is involved in the initiation of HS chains by transferring the first GlcNAc to the linkage region. Although EXT2 alone synthesized no heparan polymers on the synthetic linkage region analogue GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, marked polymerization by EXT2 alone was demonstrated on GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 N-benzyloxycarbonyl (where GlcUA is glucuronic acid and Gal is galactose), which was generated by transferring a GlcNAc residue using recombinant EXTL2 on to GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl. These findings indicate that the transfer of the first GlcNAc residue to the linkage region by EXTL2 is critically required for the biosynthesis of HS in cells deficient in EXT1.
INTRODUCTION
HS (heparan sulfate) proteoglycans are ubiquitously found at the cell surface and in the extracellular matrix, affecting a variety of biological processes, including specific signalling pathways [1] [2] [3] [4] . HS has highly heterogenous structures, with various mass and sulfation patterns, and its synthesis is spatially and temporally regulated. Therefore understanding the regulatory mechanisms of HS biosynthesis underlying diverse HS functions is essential.
The biosynthesis of HS chains is initiated by construction of the tetrasaccharide linkage region, GlcUAβ1-3Galβ1-3Galβ1-4Xylβ1-(where GlcUA is glucuronic acid, Gal is galactose and Xyl is xylose), with the Xyl attached to a serine residue in the core protein. Next, the HS chain backbone is synthesized by HS polymerases encoded by EXT1 and EXT2 [5] in the EXT (exostosin) gene family, which were first identified as causative genes of a genetic bone disorder, hereditary multiple exostoses [6, 7] , and subsequently demonstrated to function as tumour suppressor genes [8, 9] . Both EXT1 and EXT2 encode bifunctional glycosyltransferases with GlcNAcT-II (N-acetylglucosaminyltransferase II) and GlcAT-II (glucuronyltransferase II) activities that catalyse the polymerization of HS. EXT1 and EXT2 form a hetero-oligomeric complex in vivo, leading to higher glycosyltransferase activity compared with EXT1 and EXT2 alone. In addition, mutations in either EXT1 or EXT2 reduce HS levels. Thus it has been suggested that the EXT1-EXT2 heterocomplex represents the biologically functional form of HS polymerases [10, 11] .
The EXT gene family consists of five members, EXT1, EXT2, and three additional members, designated EXTL1-3 (EXT-like 1-3), on basis of the amino acid sequence similarity of their gene products to EXT1 and EXT2 proteins [12] [13] [14] [15] . The EXTL genes have not been linked to hereditary multiple exostoses, although the chromosomal loci of the genes imply that they might also encode tumour suppressors. All three EXTL proteins possess glycosyltransferase activities related to HS biosynthesis [16] ; however, in view of the findings that in vitro HS polymerization was induced using tetrasaccharide-linkage analogues as acceptor substrates for the enzyme complex of human EXT1-EXT2 without the aid of EXTL proteins [17] , the biological roles of mammalian EXTLs in HS biosynthesis are less clearly defined. Both EXTL1 and EXTL3 have been shown to exhibit GlcNAcT activities that are probably involved in the biosynthesis of HS. EXTL1 exerts only GlcNAcT-II activity, which may be involved in HS chain elongation, whereas EXTL3 possesses activity for transferring the first GlcNAc (N-acetylglucosamine) residue to the tetrasaccharide-linkage region (so-called GlcNAcT-I activity) in addition to GlcNAcT-II activities. Thus it has been speculated that EXTL1 is involved in the elongation of HS chains as a GlcNAcT-II and that EXTL3 is involved in the initiation and elongation process of HS biosynthesis as a GlcNAcT-I and GlcNAcT-II. Of the two, only EXTL3 is ubiquitously expressed in human tissues [13, 15] and is therefore more likely to be involved in the universal biosynthesis of HS. EXTL2, the shortest member of the EXT family, is an N-acetylhexosaminyltransferase that transfers not only GlcNAc, but also GalNAc (N-acetylgalactosamine) to
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the linkage region through α1-4 linkage [18, 19] and is the first member of the EXT gene family to be crystallized as a ternary complex with UDP and the acceptor substrate [20] . Thus EXTL2 could physiologically function as a GlcNAcT-I, an α-GalNAcT (galactosaminyltransferase) or both. In contrast with other members of the EXT gene family, orthologues of mammalian EXTL1 and EXTL2 are absent in Drosophila, suggesting that these genes might be dispensable for HS biosynthesis. An essential function of EXT1 in HS polymerization has been indicated by the findings that HS synthesis is blocked in EXT1-deficient embryonic stem cells [21] and in Drosophila with a mutation in ttv (tout-velu), the orthologue of human EXT1 [22] . Therefore it has been thought that HS chains cannot be synthesized in the absence of EXT1. In the present paper we show that small amounts of HS chains are still produced in cells defective in EXT1 [in a mouse L fibroblast mutant cell-line, called gro2C, and the HL60 cell-line (human promyelocytic leukaemia cells)]. Interestingly, the HS chains in EXT1-deficient cells were shorter than those in the corresponding EXT1-expressing cells. Finally, we propose the biosynthetic mechanism for HS chain formation in EXT1-deficient cells.
EXPERIMENTAL

Cell lines
Mouse L fibroblasts and their derivatives, gro2C, were provided by Dr Frank Tufaro (Allera Health Products, St Peterburg, FL, U.S.A.). HL60 cells, a human promyelocytic leukaemia line, were obtained from the RIKEN Cell Bank (number RCB0041).
Cell culture and stable transfection
Cells were grown in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % (v/v) fetal bovine serum in a 5 % CO 2 incubator at 37
• C. MISSION TM plasmids for expressing of sh (short hairpin) EXT2 and shEXTL2 (Sigma-Aldrich), and pLKO.1-Puro empty vector (SigmaAldrich) and Sure Silencing TM shEXTL3 plasmids (SuperArray Bioscience) were transfected into gro2C cells using FuGENE TM 6 transfection reagent (Roche Diagnostics) according to the manufacturer's instructions. Cells transfected with the shEXT2-or shEXTL2-expressing plasmids were cultured in the presence of 10 μg/ml puromycin (Sigma-Aldrich). Cells transfected with the shEXTL3-expressing plasmid were cultured in the presence of 400 μg/ml G418 (Invitrogen). Antibiotic-resistant clones were then picked up and propagated for experiments.
Isolation of total RNA and qRT-PCR (quantitative real-time PCR)
Total RNA was extracted from cells using TRIzol ® reagent (Invitrogen). Aliquots of 1 μg of total RNA were transcribed to produce cDNA using MMLV (Moloney-murine-leukaemia virus) reverse transcriptase (Promega) and a random primer according to the manufacturer's instructions. qRT-PCR was conducted using a FastStart DNA Master plus SYBR Green I in a LightCycler 1.5 (Roche Applied Science). The housekeeping gene GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as a reference gene for quantification. Specific primers for human and mouse EXT genes and GAPDH were designed using the LightCycler Probe Design Software version 3.3 (Roche Applied Science). The expression level of the EXT mRNAs was normalized to that of the GAPDH transcripts. The primers used for qRT-PCR are shown in Supplementary Table S1 (available at http://www.BiochemJ.org/bj/428/bj4280463add.htm).
Isolation and purification of GAGs (glycosaminoglycans)
Cells grown at 100 % confluency were homogenized in acetone, and cell extracts were prepared by three acetone extractions, followed by thorough air-drying. The dried materials were digested with heat-activated actinase E [10 % (w/w) of dried materials] in 0.1 M borate/sodium, pH 8.0, containing 10 mM CaCl 2 , at 55
• C for 48 h. The samples were adjusted with 22 μl of 50 % (v/v) trichloroacetic acid and centrifuged (9100 g for 10 min). The resultant supernatants were extracted with 300 μl of diethyl ether three times to remove the trichloroacetic acid. Then 80 % (v/v) ethanol, containing 5 % (w/v) sodium acetate, was added to the aqueous phase, and left overnight at − 20
• C. The resultant precipitate was dissolved in 50 mM pyridine acetate, pH 5.0, and subjected to gel filtration on a PD-10 column (GE Healthcare) using 50 mM pyridine acetate, pH 5.0, as an eluent. The flow-through fractions were collected and dried by evaporation.
Disaccharide composition analysis of HS
Purified GAGs were digested with a mixture of 0.5 m-units heparinase and 0.5 m-units heparitinase in 20 mM sodium acetate, pH 7.0, containing 2 mM calcium acetate, at 37
• C for 4 h. Reactions were terminated by boiling for 1 min. The digests were labelled with the fluorophore 2-aminobenzamide and then analysed by HPLC as reported previously [23] .
Determination of the molecular mass of GAG chains
Isolated GAG chains were subjected to gel-filtration chromatography using a Superdex 200 HR 10/30 column (GE Healthcare) [17] . The column was eluted with 0.2 M NH 4 HCO 3 at a flow rate of 0.4 ml/min. Fractions were collected, freezedried and digested with a mixture of 1 m-unit heparinase and 1 m-unit heparitinase in 20 mM sodium acetate, pH 7.0, containing 2 mM calcium acetate, at 37
• C for 4 h. The resultant digests were labelled with 2-aminobenzamide and analysed by anion-exchange HPLC as described previously [23] .
Expression of soluble forms and enzyme assays of EXT1 and EXT2
Soluble forms of EXT1 and EXT2 fused with the cleavable insulin signal sequence and the Protein A IgG-binding domain were constructed as described previously [17] . The expression plasmid (6.0 μg) was transfected into COS-1 cells on 100-mmdiameter plates using FuGENE TM 6 (Roche Applied Science) according to the manufacturer's instructions. For co-transfection experiments, 3.0 μg of each expression plasmid was cotransfected into COS-1 cells on 100-mm-diameter plates as above. After a 2-day culture at 37
• C, 1 ml of the culture medium was collected and incubated with 10 μl of IgGSepharose (GE Healthcare) for 1 h at 4
• C. The beads were recovered by centrifugation (1500 g for 2 min), and were washed with and resuspended in the assay buffer (described below). A polymerization reaction, using 1 nmol GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl as an acceptor, was conducted in assay buffer (20 μl total volume) comprising 100 mM Mes, pH 5.8, 10 mM MnCl 2 , 0.25 mM UDP-GlcUA and UDP-[ 3 H]GlcNAc (5.5 × 10 5 c.p.m.) (PerkinElmer Life Sciences) and 10 μl of the suspended beads as described previously [17] . The mixtures were incubated at 37
• C overnight, then radiolabelled products were separated from UDP-[ 
Preparation of a synthetic trisaccharide analogue (GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl) as a polymerization primer
Trisaccharide analogues were prepared by adding a GlcNAc residue to GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, taking advantage of the GlcNAcT-I activity of EXTL2. Soluble forms of EXTL2 were prepared, and EXTL2-bound beads were resuspended and used for the reactions as described previously [19] . The reaction mixture (a total volume of 20 μl) contained 100 mM Mes buffer, pH 6.5, 10 mM MnCl 2 , 30 nmol GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl (as an acceptor), 6 pmol UDP-[
3 H]GlcNAc (7.9 × 10 5 c.p.m.), 30 nmol UDP-GlcNAc (PerkinElmer Life Sciences), 1 mM ATP and 10 μl of suspended beads. The mixtures were incubated at 37
• C overnight, and then radiolabelled products were isolated by HPLC on a NovaPak ® C18 column (3.9mm × 150 mm; Waters) as described previously [19] . The fractions containing radioactive products were pooled and dried by evaporation. Excess GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl in the radioactive fractions was digested with β-D-glucuronidase (EC 3.2.1.31) from bovine liver (Sigma-Aldrich) to prevent it from serving as an acceptor for polymerization.
RESULTS
Gro2C cells defective in EXT1 synthesize small amounts of HS
Previous studies have shown that gro2C cells, a mouse L cell mutant, are deficient in the expression of EXT1, which encodes a glycosyltransferase related to the formation of the HS backbone, and thereby do not synthesize HS chains [24] . In the present study, however, characterization of GAGs isolated from L and gro2C cells with a mixture of heparinase and heparitinase revealed that gro2C cells synthesized a small but significant amount of HS, which was ∼ 15 % of the amount produced by L cells ( Figure 1A ). In addition, N-sulfation was increased in the gro2C cells compared with the L cells ( Figure 1C ), suggesting that loss of EXT1 affected the fine structure of HS chains (see Discussion). The mRNA expression levels of EXT family members in L and gro2C cells were analysed by qRT-PCR ( Figure 1B ). As expected, EXT1 mRNA expression was not detected in gro2C cells. In addition, there were no differences in the mRNA expression levels of EXT2, EXTL1, EXTL2 and EXTL3 between L and gro2C cells. Busse et al. [25] indicated that the gene silencing of EXT1, EXT2 or EXTL3 does not affect the transcript levels of other EXT genes, consistent with our results that loss of EXT1 in gro2C cells had no effects on the mRNA levels of other EXT genes. It was also observed previously that mice carrying a hypomorphic mutation in EXT1 synthesize shorter HS chains, approximately one-third the length of wild-type [26] . Hence, to examine whether the decrease in the amount of HS in gro2C cells was the result of a reduction in the length of HS, HS chains obtained by reductive β-elimination using alkali from L and gro2C cells were subjected to gelfiltration chromatography on a Superdex 200 column. As shown in Figure 1(D) , gro2C cells produced shorter HS chains than L cells. According to the calibration curve given by measuring the elution positions of size-defined commercial dextran preparations, the average molecular mass of the HS chains in L and gro2C cells was approx. 75 and 48 kDa respectively. These results indicate that, as in the case of mice generated by the gene-trap method, which were reported to produce a small amount of wild-type EXT1 transcript [26] , gro2C cells completely defective in EXT1 expression indeed form shorter HS chains.
HL60 cells defective in EXT1 also synthesize HS chains
It has been reported previously that transcriptional inactivation of EXT1 by CpG island promoter hypermethylation occurs in HL60 cells, leading to loss of EXT1 expression [27] . We found that EXT1 mRNA was not expressed in HL60 cells, whereas EXT2, EXTL2 and EXTL3 were produced (Figure 2A) . We next examined whether HL60 cells also synthesize a small number of HS chains. We found that HL60 cells indeed produced a detectable amount of HS without the assistance of EXT1, as was the case for gro2C cells ( Figure 2B ). HL60 cells synthesized about 10 % (w/w) of the amount of HS synthesized in HL60 cells treated with a DNA demethylating agent, AZA (5-aza-2 -deoxycytidine) [28] , by which the epigenetic loss of EXT1 function can be restored [27] . These results indicate that a small amount of HS is synthesized in HL60 cells defective in the expression of EXT1. Deficiency in EXT1 had a marginal effect on HS disaccharide composition in HL60 cells ( Figure 2C ; see the Discussion section). AZA also diminished the mRNA expression levels of EXTL3, in addition to EXT1 (Figure 2A [27, 29] . Furthermore, the length of HS chains synthesized in HL60 cells was examined. As shown in Figure 2(D) , there was a decrease in the amount of HS chains with lengths of 8-37 kDa produced in HL60 cells compared with cells treated with AZA. These results suggest that EXT1-deficient cells produce shorter HS chains.
EXTL2 plays an important role in HS biosynthesis in EXT1-deficient gro2C cells
As EXT2 alone exhibits no HS polymerization activity for the synthetic linkage region analogue GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl [17] , we next investigated the involvement of EXTL proteins in HS biosynthesis in gro2C cells. Among the three EXTL genes, EXTL2 and EXTL3 are ubiquitously expressed in human tissues [13, 15, 19] , whereas EXTL1 is reported to be expressed in limited areas, such as the skeletal muscles, brain and heart [13] . EXTL1 mRNA was expressed at a very low level in gro2C and HL60 cells ( Figures 1B  and 2A ). In addition, both EXTL2 and EXTL3 have the capacity to transfer a GlcNAc residue to the tetrasaccharide linkage region and to initiate HS biosynthesis. Therefore we examined whether EXTL2 or EXTL3 might contribute to HS biosynthesis in EXT1-deficient cells. Gro2C cells stably transfected with a mouse EXT2, EXTL2 or EXTL3 shRNA-expressing vector were established. As determined by qRT-PCR, the target mRNA expression level was reduced to no more than 25 % that of the control cells ( Figures 3A, 3C and 3E) . To investigate the contributions of EXT2, EXTL2, and EXTL3 to HS biosynthesis in gro2C cells, HS chains were isolated from each cell and analysed. Knockdown of EXT2 decreased the amount of HS by approx. 75 % ( Figure 3B ; Supplementary Table S2, at http://www.BiochemJ.org/bj/428/bj4280463add.htm), suggesting that EXT2 may function as an HS polymerase in gro2C cells. A decrease in the expression level of EXTL2 reduced the amount of HS by > 50 % ( Figure 3D and Supplementary Table S2 ). In contrast, knockdown of EXTL3 had little effect on the amount of HS synthesis but affected sulfation patterns of HS in gro2C cells ( Figure 3F and Supplementary Table S2 ). These results indicate that EXT2 and EXTL2 work together to produce HS chains in EXT1-deficient cells. 
EXTL2 acts as GlcNAcT-I to initiate HS biosynthesis in EXT1-deficient cells
It has been reported previously that recombinant soluble enzymes expressed by the co-transfection of EXT1 and EXT2 exhibit polymerization activities and synthesize heparan polymer on the synthetic linkage region analogue, GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl [17] . In contrast, no significant polymerization was reported to occur on GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl when EXT1 and EXT2 were expressed individually [17] . Thus we speculated that even EXT1 and EXT2 alone could polymerize HS chains to some extent, provided that the first GlcNAc has been transferred on to the linkage region by EXTL2. For this analysis, GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, which was generated by transferring a GlcNAc residue using recombinant EXTL2 on to GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, was used as an acceptor in the polymerization reaction. Separately expressed EXT1 or EXT2 could utilize GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl as an acceptor and exhibited weaker, yet significant, polymerization activities compared with co-expressed EXT1-EXT2 (Figure 4) . However, the chain length of the products formed by EXT1 or EXT2 alone was shorter than that formed by co-expressed EXT1-EXT2. As EXT1 and EXT2 form a hetero-oligomeric complex in vivo, we examined whether or not EXT1 proteins in COS-1 cells were co-purified with recombinant soluble EXT2 proteins. Bands corresponding to EXT1 proteins were not detected in the purified recombinant EXT2 proteins (Supplementary Figure S1A at http://www.BiochemJ.org/bj/428/bj4280463add.htm). In contrast, recombinant EXT2 proteins retained in the cells indeed interacted with EXT1 as reported [10, 11] . In addition, because COS-1 cells hardly express EXTL1 (Supplementary Figure S1B) , it is unlikely that EXTL1 proteins were contained in the purified recombinant EXT2 proteins. Furthermore, as suggested previously [11, 30] , EXT2 could not form a complex with EXTL3 (Supplementary Figure S1C) . These results demonstrate that EXT2 alone can achieve HS polymerization with the aid of the GlcNAcT-I activity of EXTL2, even in the absence of EXT1 ( Figure 5 ).
DISCUSSION
Previous reports indicate that biologically functional HS polymerase is a complex containing EXT1 and EXT2. The two proteins, when expressed together, exhibit a much higher level of glycosyltransferase activity than when individually expressed proteins [10, 11] . Co-expressed EXT1-EXT2 is able to synthesize heparan polymers without the support of additional factors [17, 31] . In addition, EXT1 and EXT2 do not appear to be functionally redundant in vivo, because deficiency in either one can cause a remarkable decrease in the amount of HS [21, 32, 33] . Thus all of these findings suggest that the EXT1-EXT2 complex is essential and sufficient for the biosynthesis of HS. It has been shown that HS chains are still produced in cells treated with either EXT1 siRNA (small interfering RNA) or EXT2 RNA, although the respective mRNA expression levels fell to below 10 % of that of control RNA-treated cells [25] . Likewise, mouse embryonic fibroblasts carrying a hypomorphic mutation in EXT1 synthesized approx. 18 % of HS chains compared with wild-type cells. However, both EXT1 siRNA-treated cells and fibroblasts with a hypomorphic mutation in the EXT1 gene resulted in the profound reduction, but not complete elimination of EXT1 transcripts [26] . It was therefore thought that residual EXT1 participates in HS biosynthesis. In the present study, we used a mouse L cell mutant, called gro2C, which contains a specific defect in the EXT1 gene and consequently synthesizes a non-functional truncated EXT1 protein [11, 24] . Interestingly, gro2C cells also formed a small but significant number of HS chains ( Figure 1A ). Taken together, these results clearly indicate that small amounts of HS can be synthesized even in the absence of EXT1.
Three EXTL genes, which share significant sequence similarity with EXT1 and EXT2, have been identified. EXTL1, EXTL2 and EXTL3 all encode proteins with glycosyltransferase activities related to HS biosynthesis [16, 19] ; however, their roles in HS biosynthesis in vivo remain unclear. In the present study,
Figure 4 In vtiro heparan polymerization catalysed by EXT1, EXT2 or coexpressed EXT1-EXT2
GlcNAcα1-4GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, which was generated by transferring a GlcNAc residue using recombinant EXTL2, was used as an acceptor for polymerization reactions. The polymerization reactions were carried out as described the Experimental section using individually expressed EXT1 (᭺), EXT2 (᭹) or co-expressed EXT1-EXT2 ( ) as an enzyme source. The polymerized products were analysed on a Superdex 200 column and the eluted fractions were measured by radioactivity. The elution positions of molecular-mass-markers are indicated. V o , void volume.
Figure 5 Role of EXTL2 in HS biosynthesis in EXT1-deficient cells
Upper panel: in the presence of EXT1, an EXT1-EXT2 complex has dual functions to initiate HS biosynthesis and polymerize HS chains. EXTL3 is also involved in transferring the first GlcNAc to the tetrasaccharide linkage region as a GlcNAcT-I. EXTL3 might be indispensable for HS biosynthesis, and regulate the number and length of HS chains. Lower panel: in the absence of EXT1, EXT2 alone cannot execute HS polymerization because of a lack of GlcNAcT-I activities. Thus EXTL2 is required for initiation of HS biosynthesis. Given that the first GlcNAc is transferred on to the linkage region by EXTL2, EXT2 can polymerize HS chains. The length of HS chains produced without the aid of EXT1 is shorter than that synthesized by the EXT1-EXT2 complex. Ser, serine residue.
we demonstrated that the GlcNAcT-I activity of EXTL2 was required for HS synthesis in EXT1-deficient cells. As shown in Figure 3 , expression of shRNA to knockdown EXT2 or EXTL2 depressed HS biosynthesis in gro2C cells to a similar extent, suggesting a distinct function for EXT2 and EXTL2 in HS biosynthesis in EXT1-deficient cells. We therefore thought that transfer of the first GlcNAc residue on to the tetrasaccharide linkage by EXTL2 might be needed for the HS polymerization process which would be mediated by EXT2 alone. As expected, EXT2 alone could form no heparan polymers on the synthetic linkage analogue GlcUAβ1-3Galβ1-O-C 2 H 4 NH-benzyloxycarbonyl, but the transfer of GlcNAc to the synthetic linkage analogue by EXTL2 allowed EXT2 to synthesize HS chains (Figure 4) . In contrast, knockdown of EXTL3 had little effect on the amount of HS in EXT1-deficient cells, although EXTL3 also possesses GlcNAcT-I activities like EXTL2. In fact, the amounts of HS were markedly decreased by knockdown of EXTL3 in EXT1-expressing L cells (results not shown). In addition, EXTL3-knockout mice have been generated and HS biosynthesis is reported to be severely reduced in EXTL3-null embryos [34] . These results suggest that EXTL3 might mainly function as a GlcNAcT-I in the presence of EXT1 ( Figure 5 ). Although EXTL3 cannot directly interact with EXT1 (Supplementary Figure S1C ; [30] ), it might be associated with a polymerase complex consisting of EXT1 and EXT2 via other adaptor proteins.
The functional importance of GlcNAcT-I activities in HS biosynthesis has been demonstrated in several in vivo model animals. In Drosophila, there are three orthologues of mammalian EXT genes, ttv (an EXT1 orthologue), EXT2 (also known as sotv, sister of tout-velu) and botv (brother of tout-velu) an EXTL3 orthologue. Biochemical and immunohistochemical studies on Drosophila have revealed that HS levels are markedly reduced or abolished in the absence of ttv, sotv or botv [30, 35, 36] . Although the Ttv-Ext2 complex can catalyse the HS polymerization reaction in vitro, in contrast with the human EXT1-EXT2 complex, the complex does not exhibits the GlcNAcT-I activity required for the initiation of HS [37] , indicating that Botv, corresponding to human EXTL3, which possesses GlcNAcT-I activity, is indispensable for HS biosynthesis in Drosophila [38] . In this regard, Han et al. [30] demonstrated that botv-null embryos exhibited stronger segment polarity phenotypes than ttv-or sotvnull embryos and that Wg (wingless) signalling is defective in the botv mutant and ttv/sotv double-mutant, but not in the ttv or sotv mutant. These results together suggest that Botv is essential for the initiation of HS and that all three EXT members, ttv, sotv and botv, are required for HS biosynthesis in Drosophila. In mammals, the enzyme complex of human EXT1-EXT2 without the aid of EXTL proteins can synthesize HS chains [17] ; however, in view of the present results, the transfer of the first GlcNAc residue to the tetrasaccharide-linkage region by EXTL2 is thought to trigger HS biosynthesis in the absence of EXT1.
EXT genes are well conserved in mammals, Zebrafish (ext1, ext2/dackel and extl3/boxer), Drosophila (see above) and Caenorhabditis elegans (ext1/rib1 and extl3/rib2). Hence, EXT1 and EXTL3 are present in genomes from worms to higher eukaryotes, suggesting that primitive HS chains are synthesized in concert with EXT1 and EXTL3. However, the amount of HS in C. elegans is much smaller that in other organisms because the polymerization by Rib1-Rib2 is not efficient [39] . EXT2 seems to have appeared later in evolution, probably because higher organisms need higher levels of HS than worms. After EXT2 emerged in the course of evolution, EXTL3 continued to play an essential role in the biosynthesis of HS. It has been reported that mutations in EXTL3 markedly reduced HS levels in Zebrafish [40] , Drosophila [30, 35, 36] and mice [34] , suggesting that EXTL3 is implicated in the initiation of HS biosynthesis as a GlcNAcT-I in these organisms. The EXTL2 gene exists only in mammalian genomes, and its function remains unclear. Our present study shows that low levels of HS were synthesized by EXT2 and EXTL2 in EXT1-deficient cells. It was reported that mice with disrupted EXT1 survived until embryonic day 8.5 [21] , suggesting that residual HS synthesized by EXT2 and EXTL2 functions in early embryogenesis. It is possible that double-knockout mice lacking EXT1, and EXTL2 or EXT2 would die earlier than EXT1-deficient embryos.
A complex called a 'GAGosome', in which the biosynthetic enzymes physically interact in a multimeric complex and co-ordinate GAG production, has been proposed [41] . The different composition of the GAGosome may result in different modification patterns of the GAG chain, so that loss of one component can have effects on the fine structure of GAG chains. Most recently, Presto et al. [42] reported that EXT1 and EXT2 affected NDST1 (N-deacetylase/N-sulfotransferase-1) expression and the sulfation pattern of HS chains. The authors of that study proposed that the interaction of NDST1 with EXT2 enhances the protein stability of NDST1, leading to increased NDST activities. Most EXT2 molecules bind not to NDST1, but to EXT1, because the affinity of EXT1-EXT2 is greater than NDST1-EXT2. In the absence of EXT1, NDST1 forms a complex with EXT2, resulting in increased N-sulfation levels of HS chains. Consistent with these observations, N-sulfation of HS chains increased in EXT1-deficient gro2C cells ( Figure 1C ). In contrast, lack of EXT1 expression had little effect on N-sulfation levels of HS chains synthesized in HL60 cells ( Figure 2C ). AZAtreated HL60 cells synthesized HS chains highly modified with N-sulfation regardless of the expression of EXT1 ( Figure 2C ). As the relative expression level of EXT2 compared with EXT1 was higher in HL60 cells treated with AZA than in L cells, a GAGosome consisting of NDST1-EXT2 might be formed in HL60 cells treated with AZA, even in the presence of EXT1. The relative concentration of EXT1 and EXT2 will greatly influence the sulfation pattern of HS synthesized as predicted in the GAGosome model. In addition, 2-O-sulfation was greatly reduced in gro2C cells ( Figure 1C ; Supplementary Table S2 ), suggesting that deficiency of EXT1 may attenuate 2-O-sulfation and consequently increase N-sulfation, although interactions between EXT1 and Hs2st1 (HS 2-O-sulfotransferase 1) have not been reported. In this regard, it should be noted that loss of 2-O-sulfation increases N-sulfation, as shown with the analysis of Hs2st1-null mice [43] . Moreover, there is an additional layer of complexity in that knockdown of EXTL3 in EXT1-deficient cells further decreased 2-O-sulfation and increased Nsulfation (Supplementary Table S2 ). Thus differential expression of each enzyme can have profound effects on the fine structure of HS.
Notably, the chain length in HL60 cells was considerably shorter than that in L cells. HL60 cells predominantly synthesize heparin proteoglycans called 'serglycin'. The length of heparin chains on a serglycin synthesized by mouse mastocytoma has been reported to be 20 kDa [44] . In contrast, L cells produce HS proteoglycans, such as the syndecan family. For example, the length of HS chains on syndecan-4 has been reported to be 36-42 kDa [45] . Thus the chain length might be dependent on which core proteins are synthesized in a given tissue. Alternatively, EXTL3, which is involved in the initiation and elongation processes of HS biosynthesis, might play critical roles in chain elongation of HS. In fact, the expression level of EXTL3 in L cells was significantly higher than that in HL60 cells ( Figures 1B  and 2A) , suggesting that EXTL3 might regulate the length of HS chains. In addition, it is of interest to consider the biological significance of a small number of short HS chains by taking into account previous results obtained through experiments with EXT1-deficient cells. Previous reports indicate that bFGF (basic fibroblast growth factor) significantly binds to HL60 cells and that the binding of bFGF to HL60 cells is reduced by heparin [46] . bFGF has been identified as an important cytokine for blood cells and is known to utilize HS protoglycans as a low-affinity receptor. As shown in Figure 2 (B), HL60 cells produce only a small number of short HS chains. Thus the low numbers of HS chains produced by HL60 cells might be implicated in bFGFstimulated proliferation. Alternatively, structural changes caused by the absence of EXT1 ( Figure 1C and Supplementary Table S2 ) might contribute to the function of short HS chains. Thus a small number of short HS chains synthesized in the EXT1-deficient cells might also be functional in vivo.
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